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Available online 2 June 2014AbstractTranexamic acid (TXA) is an antifibrinolytic agent that is commonly used in cardiac, gynecologic, and obstetric surgeries. Inadvertent
intrathecal injection of the TXA may lead to serious side effects including myoclonus, seizure, and ventricular fibrillation. So far, the pro-
convulsive properties of TXA and its mechanism of action are poorly understood. Medical error leads to serious adverse effects that can be
attributed to similar appearance of ampoules, location of ampoules, and incorrect labeling of prefilled syringes. We herein report a case of
refractory status epilepticus after accidental intrathecal injection of TXA. The patient was treated with thiopentone infusions until achieving a
burst suppression pattern on electroencephalogram along with other antiepileptic drugs. Subsequently, the patient recovered completely without
any neurological deficit. To the best of our knowledge, this is the first case of refractory status epilepticus after inadvertent intrathecal injection
of TXA. Such catastrophic complications can be avoided by vigilance, correct labeling of syringes and ampoules, double checking medications
prior to administration, and preventing manufacturing of vials of different drugs with similar appearance.
Copyright  2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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In industrialized countries, the major cause of injury and
death in many health centers and hospitals is medication errors.
Most of these cases can be prevented by vigilance, correct la-
beling of syringes and ampoules, double checking medications
prior to administration, and preventing manufacturing of vials
of different drugs with similar appearance. Tranexamic acid
(TXA) is an antifibrinolytic agent that is commonly used in
cardiac, gynecologic, and obstetric surgeries. Recently, TXA
has been shown to be associated with an increased incidence of
postoperative seizures in cardiac patients. Higher frequency of* Corresponding author. Advanced Neurocare Institute, GBH American
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Udaipur, Rajasthan 313001, India.
E-mail addresses: atulabh@gmail.com, atulabh@gbhamericanhospital.com,
drgauravjaipur@yahoo.com (A. Vajpayee).
http://dx.doi.org/10.1016/j.jacme.2014.02.004
2211-5587/Copyright  2014, Taiwan Society of Emergency Medicine. Publishedseizures has been reported in patients with preoperative renal
failure, open heart surgery, and older age.1 The proconvulsive
properties and the underlying pathophysiology of TXA have
not been completely understood yet. In this case report, we
report a case of refractory status epilepticus due to accidental
administration of intrathecal TXA injection instead of bupi-
vacaine for spinal anesthesia.
2. Case Report
A 36-year-old American Society of Anaesthesiologists I
physical status male was scheduled for herniorrhaphy for left
inguinal hernia in a peripheral hospital in western India. A
thorough preanesthetic checkup was done. The patient had no
prior history of seizures, neurological illness, exposure to
anesthesia, or drug allergy. Baseline monitors (pulse oximetry,
noninvasive blood pressure, and electrocardiogram) wereby Elsevier Taiwan LLC. All rights reserved.
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administered to the patient in the sitting position at the L3eL4
interspace by a 27-gauge atraumatic spinal needle. An injec-
tion of 2.5 mL 0.5% hyperbaric bupivacaine and 25 mg fentanyl
was prepared for intrathecal administration. After the intra-
thecal injection, the patient was placed in the supine position; 1
minute later, the patient complained of pain in the back and in
both lower limbs. The partial effect of spinal anesthesia was
therefore supplemented with an intravenous injection of fen-
tanyl (100 mg) and midazolam (2 mg) prior to surgery. How-
ever, 30 minutes after the administration of intrathecal
injection, the patient again complained of pain in the back and
in both lower limbs. Within a few minutes, he developed tonic
deviation of all four limbs with uprolling of his eyeballs. At
that time, his blood pressure was 170/100 mmHg and pulse rate
was 115/minute. The patient had oxygen saturation of 100% on
air.
Since then, he developed recurrent generalized toniceclonic
seizures (GTCSs). The patient received an injection of loraze-
pam (4 mg). Despite three repetitive injections of intravenous
lorazepam, he had recurrent GTCS. In between seizures, he
remained in altered sensorium. A loading dose of phenytoin
(20 mg/kg) was intravenously infused over 20 minutes to
control the seizures; however, the infusion had no effect.
Therefore, a bolus of propofol (60 mg) was administered
intravenously, followed by infusion of propofol at a rate ofFig. 1. (A) Ongoing epileptiform discharges in the electroencephalography (EEG) re
Normalization of the EEG findings after controlling the status epilepticus. (D) Norm
recovery sequence).120 mg/kg/minute. He was intubated with an 8.5-mm cuffed
polyvinyl chloride endotracheal tube and put on the mechanical
ventilator support. Following intubation, he was shifted to our
hospital for further management. Accidental intrathecal
administration of a wrong drug was suspected. On inquiry, the
used ampoule of TXAwas found in the anesthesia tray. Because
the patient had recurrent GTCS with altered sensorium in the
emergency room, the dose of propofol was increased and he
was shifted to the neurointensive care unit. Scalp electroen-
cephalography (EEG) was performed, which showed ongoing
status epilepticus. He had refractory status epilepticus as
intermittent breakthrough seizures with ongoing seizure activ-
ity on EEG. We decided to induce coma with thiopentone. An
intravenous bolus of thiopentone injection was given (5 mg/kg
over 20 minutes), followed by infusion of the drug at a rate of
2 mg/kg/hour. The dose of infusion was subsequently increased
up to 15 mg/kg/hour until a burst suppression pattern was
achieved (Fig. 1). The dose of thiopentone was tapered after 6
hours of a clinical and electroencephalographic seizure-free
period. Doses of thiopentone and propofol were gradually
tapered over 24 hours. The patient was put on a maintenance
dose of phenytoin with clobazam. His sensorium started to
improve after 72 hours, and he was extubated after 4 days.
Magnetic resonance imaging of the brain was performed, and
the results were normal (Fig. 1). He was discharged after 7 days
without any neurological deficit.cording. (B) Burst suppression in the EEG recording induced by thiopental. (C)
al magnetic resonance imaging brain (axial cut of the fluid attenuated inversion
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TXA is a widely used antifibrinolytic agent. It is associated
with minor gastrointestinal side effects such as nausea, vom-
iting, or diarrhea. In experimental studies, topical application
of the TXA to the cerebral cortex of the experimental animals
is reported to produce seizures.2,3 In one experimental study, it
has been shown to cause systemic as well as intracranial hy-
pertension and seizures.3 Its epileptic property is directly
proportional to the concentration of the drug and area of the
exposed cortex.
Little is known about the direct application of TXA to the
human cortex. For the first time in humans, Wong et al4 re-
ported a case of inadvertent intrathecal injection of TXA. In
their case report, an 18-year-old man developed myoclonus,
generalized seizure, and persistent sensory block of both lower
extremities after an inadvertent intrathecal injection of TXA.
His seizure responded to intravenous administration of diaz-
epam. Since then, many case reports were published on the
side effects of inadvertent intrathecal injection of TXA. In
another case report, De Leede-van der Maarl et al5 reported a
case of a 68-year-old male, who inadvertently received 50 mg
of TXA intrathecally. Immediately after the intrathecal injec-
tion, he developed status epilepticus that was managed with
diazepam and thiopental. The patient survived with bilateral
peroneal palsy. Sabzi et al6 reported a case of a 30-year-old
female who inadvertently received an epidural injection of
TXA for epidural analgesia instead of bupivacaine. The patient
developed severe pain in the back and gluteal region imme-
diately after the injection. Her cesarean section was performed
under general anesthesia because of inappropriate spinal
analgesia. Just after the cesarean section, she developed
myoclonus and generalized seizure. The seizure responded to
intravenous administration of diazepam. Subsequently, she
developed refractory ventricular fibrillation and died. The
mechanism of convulsion and ventricular fibrillation of intra-
thecal injection of TXA is not known. It was postulated that
high doses of the drug would lead to massive sympathetic
surge, which results in the systemic hypertension and ven-
tricular fibrillation.
Our patient developed refractory status epilepticus after an
inadvertent intrathecal injection of TXA. The patient required
continuous infusion of thiopentone to induce burst suppression
pattern. Triggering of seizures may be explained by suppres-
sion of the inhibitory gamma-aminobutyric acid (GABA)-A
receptors in the cerebral cortex or by direct cerebral ischemia
as a result of reduced cerebral blood flow.7 Activation of
GABA-A receptors results in opening of the neuronal chloride
channels with subsequent neuronal hyperpolarization and
suppression of the neuronal excitability. Blockade of GABA-A
receptor by the TXA leads to lower threshold for neuronal
depolarization and enhanced neurotoxicity.7In the literature, status epilepticus has been reported
because of inadvertent intrathecal injection of the TXA;
however, there is no report on refractory status epilepticus
secondary to intrathecal injection of the TXA.5 Treatment of
intrathecal injection of the TXA includes administration of the
anticonvulsants, intensive hemodynamic monitoring, and if
required, cerebrospinal fluid (CSF) lavage.8 CSF lavage
removes and dilutes the injected drug and limits the neuronal
excitotoxic damage. In our case, CSF lavage could not be
performed as the patient presented after 3 hours of onset of the
seizure.
In conclusion, in all the previous case reports, inadvertent
intrathecal injection of the TXA instead of hyperbaric bupi-
vacaine was given because of the similarity of appearance of
the both ampoules. This is probably the first case report of
refractory status epilepticus after inadvertent intrathecal in-
jection of the TXA. Such a catastrophic complication can be
avoided by unique manufacturing of the critical drugs such as
spinal anesthetic drugs. At the same time, health care pro-
fessionals should adhere to the double checking concept to
prevent such deadly but avoidable complication.
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